KATO MEDICAL ApS: Financial statements 2025
CVR: 30703391
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
KATO MEDICAL ApS (CVR 30703391) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -35,921 and a net result of DKK -687,381 compared with DKK -202,605 the year before. Equity in the 2025 report amounted to DKK 750,693. The solvency ratio was 98.4%.
- Gross Profit
- DKK -35,921
- Profit/Loss
- DKK -687,381
- Equity
- DKK 750,693
- Total Assets
- DKK 762,693
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -36K | -687K | 751K | 0 |
| 2024 | - | -16K | -203K | 1.4M | - |
| 2023 | - | -15K | 469K | 1.9M | - |
| 2022 | - | -30K | 73K | 1.8M | - |
| 2021 | - | -15K | 177K | 2M | - |
Official annual report
How creditworthy is KATO MEDICAL ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
KATO MEDICAL ApS has published its annual report for 2024. Gross profit came to DKK -16,158, and the net result was DKK -202,605.
About KATO MEDICAL ApS
KATO MEDICAL ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2007. The company is registered under the industry Speciallægers aktiviteter. The management consists of Karsten Thomsen and Tove Birkebæk Thomsen. The company's owners include Karsten Thomsen, Tove Birkebæk Thomsen and Frederik Ferløv Thomsen. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -35,921 and a net result of DKK -687,381 compared with DKK -202,605 the year before. Equity in the 2025 report amounted to DKK 750,693.
